Bioventus Reports First Quarter Financial Results
07 mai 2024 07h00 HE
|
Bioventus, Inc.
Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by 15.3%Gross...
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
29 avr. 2024 07h30 HE
|
Bioventus, Inc.
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
12 mars 2024 07h30 HE
|
Bioventus, Inc.
Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...
Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024
04 mars 2024 08h00 HE
|
Bioventus, Inc.
DURHAM, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
18 janv. 2024 16h15 HE
|
Bioventus, Inc.
DURHAM, N.C., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it has entered...
Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole
12 janv. 2024 16h15 HE
|
Bioventus, Inc.
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on...
Bioventus Names Robert Claypoole as President and Chief Executive Officer
19 déc. 2023 16h30 HE
|
Bioventus, Inc.
DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of...
Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
06 déc. 2023 08h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract...
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
07 nov. 2023 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023
31 oct. 2023 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...